The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
The Continuing Challenges of Leprosy
Open accessAbstract
SUMMARY: Leprosy is best understood as two conjoined diseases. The first is a chronic mycobacterial infection that elicits an extraordinary range of cellular immune responses in humans. The second is a peripheral neuropathy that is initiated by the infection and the accompanying immunological events. The infection is curable but not preventable, and leprosy remains a major global health problem, especially in the developing world, publicity to the contrary notwithstanding.Mycobacterium leprae remains noncultivable, and for over a century leprosy has presented major challenges in the fields of microbiology, pathology, immunology, and genetics; it continues to do so today. This review focuses on recent advances in our understanding of M. leprae and the host response to it, especially concerning molecular identification of M. leprae, knowledge of its genome, transcriptome, and proteome, its mechanisms of microbial resistance, and recognition of strains by variable-number tandem repeat analysis. Advances in experimental models include studies in gene knockout mice and the development of molecular techniques to explore the armadillo model. In clinical studies, notable progress has been made concerning the immunology and immunopathology of leprosy, the genetics of human resistance, mechanisms of nerve injury, and chemotherapy. In nearly all of these areas, however, leprosy remains poorly understood compared to other major bacterial diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Classification of leprosy according to immunity. A five-group system.
Ridley, D. S., & Jopling, W. H. (1966) · PubMed · Cited by 2,466
Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.1994.03510330076038 · Cited by 1,918
Massive gene decay in the leprosy bacillus.
Cole, S. T., Eiglmeier, K., Parkhill, J., James, K. D., Thomson, N. R., Wheeler, P. R., Honoré, N., Garnier, T., Churcher, C., Harris, D., et al. (2001) · Nature · doi:10.1038/35059006 · Cited by 1,777
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R.-B., Belisle, J. T., Bleharski, J. R., Maitland, M., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,661
Immunosuppressive Drugs for Kidney Transplantation
Halloran, P. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra033540 · Cited by 1,555
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Sampaio, E. P., Sarno, E. N., Galilly, R., Cohn, Z. A., & Kaplan, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.699 · Cited by 1,192
An Antimicrobial Activity of Cytolytic T Cells Mediated by Granulysin
Stenger, S., Hanson, D. A., Teitelbaum, R., Dewan, P., Niazi, K. R., Froelich, C. J., Ganz, T., Thoma-Uszynski, S., Melián, A., Bogdan, C., et al. (1998) · Science · doi:10.1126/science.282.5386.121 · Cited by 1,065
Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
Geijtenbeek, T. B. H., van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Vandenbroucke-Grauls, C. M. J. E., Appelmelk, B., & van Kooyk, Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021229 · Cited by 1,061
Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell Clones
Salgame, P., Abrams, J. S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R. L., & Bloom, B. R. (1991) · Science · doi:10.1126/science.1681588 · Cited by 1,028
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
DC-SIGN: escape mechanism for pathogens
van Kooyk, Y., & Geijtenbeek, T. B. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1182 · Cited by 928
Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
Underhill, D. M., Ozinsky, A., Smith, K. D., & Aderem, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14459 · Cited by 827
CD1-Restricted T Cell Recognition of Microbial Lipoglycan Antigens
Sieling, P. A., Chatterjee, D., Porcelli, S. A., Prigozy, T. I., Mazzaccaro, R. J., Soriano, T., Bloom, B. R., Brenner, M. B., Kronenberg, M., Brennan, P. J., et al. (1995) · Science · doi:10.1126/science.7542404 · Cited by 740
Britton, W. J., & Lockwood, D. N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15952-7 · Cited by 687
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains
Fleischmann, R. D., Alland, D., Eisen, J. A., Carpenter, L., White, O., Peterson, J., DeBoy, R., Dodson, R., Gwinn, M., Haft, D., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.19.5479-5490.2002 · Cited by 672
DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells
Tailleux, L., Schwartz, O., Herrmann, J.-L., Pivert, E., Jackson, M., Amara, A., Legres, L., Dreher, D., Nicod, L. P., Gluckman, J. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021468 · Cited by 643
Spies, T., Bresnahan, M., Bahrain, S., Arnold, D., Blanck, G., Mellins, E., Pious, D., & DeMars, R. (1990) · Nature · doi:10.1038/348744a0 · Cited by 633
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Schlesinger, L. S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.2920 · Cited by 612
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline
Strieter, R. M., Remick, D. G., Ward, P. A., Spengler, R. N., Lynch, J. P., Larrick, J., & Kunkel, S. L. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81271-3 · Cited by 561
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
Vester, B., & Douthwaite, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.1-12.2001 · Cited by 556
Thalidomide in the treatment of lepra reactions
Sheskin, J. (1965) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196563303 · Cited by 533
Monot, M., Honoré, N., Garnier, T., Araoz, R., Coppée, J.-Y., Lacroix, C., Sow, S., Spencer, J. S., Truman, R. W., Williams, D. L., et al. (2005) · Science · doi:10.1126/science/1109759 · Cited by 490
Self-citationTakiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
Susceptibility to leprosy is associated with PARK2 and PACRG
Mira, M. T., Alcaïs, A., Van Thuc, N., Moraes, M. O., Di Flumeri, C., Hong Thai, V., Chi Phuong, M., Thu Huong, N., Ngoc Ba, N., Xuan Khoa, P., et al. (2004) · Nature · doi:10.1038/nature02326 · Cited by 473
Molecular action of methotrexate in inflammatory diseases.
Chan, E. S. L., & Cronstein, B. N. (2002) · Arthritis Research · doi:10.1186/ar419 · Cited by 463
Nigou, J., Zelle-Rieser, C., Gilleron, M., Thurnher, M., & Puzo, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7477 · Cited by 423
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells
Krutzik, S. R., Tan, B., Li, H., Ochoa, M. T., Liu, P. T., Sharfstein, S. E., Graeber, T. G., Sieling, P. A., Liu, Y.-J., Rea, T. H., et al. (2005) · Nature Medicine · doi:10.1038/nm1246 · Cited by 404
Defining protective responses to pathogens: cytokine profiles in leprosy lesions
Yamamura, M., Uyemura, K., Deans, R., Weinberg, K., Rea, T., Bloom, B., & Modlin, R. (1991) · Science · doi:10.1126/science.254.5029.277 · Cited by 392
Genetic regulation of resistance to intracellular pathogens
Skamene, E., Gros, P., Forget, A., Kongshavn, P. A. L., St Charles, C., & Taylor, B. A. (1982) · Nature · doi:10.1038/297506a0 · Cited by 372
A natural killer cell granule protein that induces DNA fragmentation and apoptosis.
Shi, L., Kraut, R. P., Aebersold, R., & Greenberg, A. H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.553 · Cited by 367
Sampaio, E. P., Kaplan, G., Miranda, A., Nery, J. A. C., Miguel, C. P., Viana, S. M., & Sarno, E. N. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.2.408 · Cited by 366
Activation and regulation of Toll-like receptors 2 and 1 in human leprosy
Krutzik, S. R., Ochoa, M. T., Sieling, P. A., Uematsu, S., Ng, Y. W., Legaspi, A., Liu, P. T., Cole, S. T., Godowski, P. J., Maeda, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm864 · Cited by 354
Prigozy, T. I., Sieling, P. A., Clemens, D., Stewart, P. L., Behar, S. M., Porcelli, S. A., Brenner, M. B., Modlin, R. L., & Kronenberg, M. (1997) · Immunity · doi:10.1016/s1074-7613(00)80425-2 · Cited by 337
The immunological functions of the vitamin D endocrine system.
Hayes, C. E., Nashold, F. E., Spach, K. M., & Pedersen, L. B. (2003) · PubMed · Cited by 329
New Twists in Gene Regulation by Glucocorticoid Receptor: Is DNA Binding Dispensable?
Karin, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81177-0 · Cited by 327
Barnes, P. F., Chatterjee, D., Abrams, J. S., Lu, S., Wang, E., Yamamura, M., Brennan, P. J., & Modlin, R. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.541 · Cited by 294
Foxp3: a critical regulator of the development and function of regulatory T cells
Hori, S., & Sakaguchi, S. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.02.020 · Cited by 291
Wallace, R. J., Meier, A., Brown, B. A., Zhang, Y., Sander, P., Onyi, G. O., & Böttger, E. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1676 · Cited by 283
Manipulating Immune Responses with Immunosuppressive Agents that Target NFAT
Kiani, A., Rao, A., & Aramburu, J. (2000) · Immunity · doi:10.1016/s1074-7613(00)80188-0 · Cited by 281
Selection of a human T helper type 1-like T cell subset by mycobacteria.
Haanen, J. B., de Waal Malefijt, R., Res, P. C., Kraakman, E. M., Ottenhoff, T. H., de Vries, R. R., & Spits, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.583 · Cited by 279
Cytokine patterns of immunologically mediated tissue damage
Yamamura, M., Wang, X. H., Ohmen, J. D., Uyemura, K., Rea, T. H., Bloom, B. R., & Modlin, R. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1470 · Cited by 273
Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients
Kang, T. (2001) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(01)00239-5 · Cited by 269
Susceptibility to Leprosy Is Linked to the Human NRAMP1 Gene
Abel, L., Sánchez, F. O., Oberti, J., Thuc, N. V., Van Hoa, L., Lap, V. D., Skamene, E., Lagrange, P. H., & Schurr, E. (1998) · The Journal of Infectious Diseases · doi:10.1086/513830 · Cited by 268
Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells
Hunger, R. E., Sieling, P. A., Ochoa, M. T., Sugaya, M., Burdick, A. E., Rea, T. H., Brennan, P. J., Belisle, J. T., Blauvelt, A., Porcelli, S. A., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419655 · Cited by 266
Kaplan, G., Walsh, G., Guido, L. S., Meyn, P., Burkhardt, R. A., Abalos, R. M., Barker, J., Frindt, P. A., Fajardo, T. T., & Celona, R. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.6.1717 · Cited by 263
Watts, C. (2004) · Nature Immunology · doi:10.1038/ni1088 · Cited by 259
Bochud, P.-Y., Hawn, T. R., & Aderem, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3451 · Cited by 257
Microbial glycolipids: possible virulence factors that scavenge oxygen radicals.
Chan, J., Fujiwara, T., Brennan, P., McNeil, M., Turco, S. J., Sibille, J. C., Snapper, M., Aisen, P., & Bloom, B. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2453 · Cited by 256
Astarie-Dequeker, C., N’Diaye, E.-N., Le Cabec, V., Rittig, M. G., Prandi, J., & Maridonneau-Parini, I. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.469-477.1999 · Cited by 253
Leprosy: too complex a disease for a simple elimination paradigm.
Lockwood, D. N. J., & Suneetha, S. K. (2005) · Europe PMC (PubMed Central) · Cited by 238
McShane, H., Brookes, R., Gilbert, S. C., & Hill, A. V. S. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.681-686.2001 · Cited by 231
E3 ubiquitin ligases as T cell anergy factors
Mueller, D. L. (2004) · Nature Immunology · doi:10.1038/ni1106 · Cited by 224 · cited 1×
“Recent work has revealed some mechanisms by which this pathway regulates the processing of protein antigens within macrophages, thereby affecting antigen presentation to lymphocytes and the resulting immune response (278, 429).”
BackgroundNg, V., Zanazzi, G., Timpl, R., Talts, J. F., Salzer, J. L., Brennan, P. J., & Rambukkana, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00142-2 · Cited by 222
Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor
Chatterjee, D., Roberts, A. D., Lowell, K., Brennan, P. J., & Orme, I. M. (1992) · Infection and Immunity · doi:10.1128/iai.60.3.1249-1253.1992 · Cited by 218
Rosat, J., Grant, E. P., Beckman, E. M., Dascher, C. C., Sieling, P. A., Frederique, D. E., Modlin, R. L., Porcelli, S. A., Furlong, S. T., & Brenner, M. B. (1999) · PubMed · Cited by 211
Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
Ponnighaus, J. M., Msosa, E., Gruer, P. J. K., Liomba, N. G., Fine, P. E. M., Sterne, J. A. C., Wilson, R. J., Bliss, L., Jenkins, P. A., & Lucas, S. B. (1992) · The Lancet · doi:10.1016/0140-6736(92)90794-4 · Cited by 208
van de Vosse, E., Hoeve, M. A., & Ottenhoff, T. H. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01203-4 · Cited by 206
Kirchheimer, W. F., & Storrs, E. E. (1972) · PubMed · Cited by 205
An overview of glucocorticoid anti-inflammatory actions
Schleimer, R. P. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf01844196 · Cited by 199 · cited 1×
“Corticosteroids Block transcription factors AP-1 and NF- B; inhibit synthesis of many proinflammatory cytokines (203, 341) (283) (276)”
BackgroundMolecular basis of rifampin resistance in Mycobacterium leprae
Honore, N., & Cole, S. T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.414 · Cited by 198
Weinberg, J. B. (1998) · Molecular Medicine · doi:10.1007/bf03401758 · Cited by 194
CD1-Restricted Microbial Lipid Antigen-Specific Recognition Found in the CD8+ αβ T Cell Pool
Rosat, J.-P., Grant, E. P., Beckman, E. M., Dascher, C. C., Sieling, P. A., Frederique, D., Modlin, R. L., Porcelli, S. A., Furlong, S. T., & Brenner, M. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.366 · Cited by 194
Tumor Necrosis Factor Promoter Polymorphism and Susceptibility to Lepromatous Leprosy
Roy, S., McGuire, W., Mascie‐Taylor, C. G. N., Saha, B., Hazra, S. K., Hill, A. V. S., & Kwiatkowski, D. (1997) · The Journal of Infectious Diseases · doi:10.1086/517282 · Cited by 192
Adams, L. B., Dinauer, M. C., Morgenstern, D. E., & Krahenbuhl, J. L. (1997) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(97)90004-6 · Cited by 187
Self-citationCD1 Expression by Dendritic Cells in Human Leprosy Lesions: Correlation with Effective Host Immunity
Sieling, P. A., Jullien, D., Dahlem, M., Tedder, T. F., Rea, T. H., Modlin, R. L., & Porcelli, S. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1851 · Cited by 185
A major susceptibility locus for leprosy in India maps to chromosome 10p13
Siddiqui, M. R., Meisner, S., Tosh, K., Balakrishnan, K., Ghei, S., Fisher, S. E., Golding, M., Shanker Narayan, N. P., Sitaraman, T., Sengupta, U., et al. (2001) · Nature Genetics · doi:10.1038/86958 · Cited by 184
T-cell release of granulysin contributes to host defense in leprosy
Ochoa, M.-T., Stenger, S., Sieling, P. A., Thoma-Uszynski, S., Sabet, S., Cho, S., Krensky, A. M., Rollinghoff, M., Nunes Sarno, E., Burdick, A. E., et al. (2001) · Nature Medicine · doi:10.1038/84620 · Cited by 175
Neural Targeting of Mycobacterium leprae Mediated by the G Domain of the Laminin-α2 Chain
Rambukkana, A., Salzer, J. L., Yurchenco, P. D., & Tuomanen, E. I. (1997) · Cell · doi:10.1016/s0092-8674(00)81927-3 · Cited by 174
Brandt, L., Skeiky, Y. A. W., Alderson, M. R., Lobet, Y., Dalemans, W., Turner, O. C., Basaraba, R. J., Izzo, A. A., Lasco, T. M., Chapman, P. L., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6622-6632.2004 · Cited by 174
Rakel, R. E., & Bope, E. T. (2006) · Therapeutische Umschau · doi:10.1024/0040-5930.63.2.164b · Cited by 173
Adams, L. B., Franzblau, S. G., Vavrin, Z., Hibbs, J. B., & Krahenbuhl, J. L. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1642 · Cited by 169
Self-citationExpression of Toll-Like Receptor 2 on Human Schwann Cells: a Mechanism of Nerve Damage in Leprosy
Oliveira, R. B., Ochoa, M. T., Sieling, P. A., Rea, T. H., Rambukkana, A., Sarno, E. N., & Modlin, R. L. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1427-1433.2003 · Cited by 168
Toll-Like Receptors and Their Function in Innate and Adaptive Immunity
Heine, H., & Lien, E. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000069517 · Cited by 162
Allavena, P., Chieppa, M., Monti, P., & Piemonti, L. (2004) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v24.i3.20 · Cited by 161
Tetracycline resistance mediated by ribosomal protection
Taylor, D. E., & Chau, A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.1 · Cited by 153
Multidrug Resistant Mycobacterium leprae from Patients with Leprosy
Maeda, S., Matsuoka, M., Nakata, N., Kai, M., Maeda, Y., Hashimoto, K., Kimura, H. J., Kobayashi, K., & Kashiwabara, Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3635-3639.2001 · Cited by 150
Polymerase Chain Reaction for the Detection of Mycobacterium leprae
Hartskeerl, R. A., de Wit, M. Y. L., & Klatser, P. R. (1989) · Microbiology · doi:10.1099/00221287-135-9-2357 · Cited by 146
Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay
Plikaytis, B. B., GELBER, R. H., & Shinnick, T. M. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.9.1913-1917.1990 · Cited by 144
Thalidomide in the treatment of leprosy
Teo, S. K., Resztak, K. E., Scheffler, M. R., Kook, K. A., Zeldis, J. B., Stirling, D., & Thomas, S. D. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01645-3 · Cited by 142
Shimoji, Y., Ng, V. H., Matsumura, K., Fischetti, V. A., & Rambukkana, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9857 · Cited by 141
Abel, L., & Démenais, F. (1988) · PubMed · Cited by 140
IL-18 Promotes Type 1 Cytokine Production from NK Cells and T Cells in Human Intracellular Infection
García, V., Uyemura, K., Sieling, P. A., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6114 · Cited by 140
Role of Tumor Necrosis Factor–α and Interleukin‐10 Promoter Gene Polymorphisms in Leprosy
Santos, A. R., Suffys, P. N., Vanderborght, P. R., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/345366 · Cited by 139
The genome of Mycobacterium leprae: a minimal mycobacterial gene set.
Vissa, V., & Brennan, P. J. (2001) · Genome biology · doi:10.1186/gb-2001-2-8-reviews1023 · Cited by 138
Understanding the multiple functions of Nramp1
Blackwell, J. M., Searle, S., Goswami, T., & Miller, E. N. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00295-1 · Cited by 136
IL-12 regulates T helper type 1 cytokine responses in human infectious disease.
Sieling, P. A., Wang, X. H., Gately, M. K., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3639 · Cited by 136
Tumor necrosis factor production in patients with leprosy
Barnes, P. F., Chatterjee, D., Brennan, P. J., Rea, T. H., & Modlin, R. L. (1992) · Infection and Immunity · doi:10.1128/iai.60.4.1441-1446.1992 · Cited by 135
Daffé, M., McNeil, M., & Brennan, P. J. (1993) · Carbohydrate Research · doi:10.1016/0008-6215(93)84102-c · Cited by 135
Kang, T. J., Lee, S., & Chae, G. (2002) · Cytokine · doi:10.1006/cyto.2002.1982 · Cited by 133
A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein.
Mehra, V. L., Bloom, B. R., Bajardi, A., Grisso, C. L., Sieling, P. A., Alland, D., Convit, J., Fan, X. D., Hunter, S. W., & Brennan, P. J. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.1.275 · Cited by 131
Interaction of dendritic cells with mycobacteria: Where the action starts
Demangel, C., & Britton, W. J. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00935.x · Cited by 127
The Role of Vitamin D in Tuberculosis
Rook, G. A. W. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.4.768 · Cited by 123
Fine, P. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401300077144 · Cited by 122
Williams, D. L., Gillis, T. P., Booth, R. J., Looker, D. L., & Watson, J. D. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.1.193 · Cited by 121
Self-citationThe Biosynthesis of Folic Acid
Richey, D. P., & Brown, G. M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91799-0 · Cited by 120
Meier, A., Heifets, L. B., Wallace, R. J., Zhang, Y., Brown, B. A., Sander, P., & Böttger, E. C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.354 · Cited by 117
Kissenpfennig, A., Aït‐Yahia, S., Clair‐Moninot, V., Stössel, H., Badell, E., Bordat, Y., Pooley, J. L., Lang, T., Prina, E., Coste, I., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.88-99.2005 · Cited by 117
Cytokine Patterns at the Site of Mycobacterial Infection
Sieling, P. A., & Modlin, R. L. (1994) · Immunobiology · doi:10.1016/s0171-2985(11)80443-2 · Cited by 114
Dallas, W. S., Gowen, J. E., Ray, P. H., Cox, M. J., & Dev, I. K. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.18.5961-5970.1992 · Cited by 111
Use of an ordered cosmid library to deduce the genomic organization of Mycobacterium leprae
Eiglmeier, K., Honoré, N., Woods, S. A., Caudron, B., & Cole, S. T. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01111.x · Cited by 109
KNOCKOUT MICE: A PARADIGM SHIFT IN MODERN IMMUNOLOGY
Mak, T. W., Penninger, J. M., & Ohashi, P. S. (2001) · Nature reviews. Immunology · doi:10.1038/3509551 · Cited by 104
Convit, J., Sampson, C., Zúñiga, M., Plata, J., da Silva, J. B., Molina, J., Pinardi, M. E., Salgado, A., Smith, P. G., & Bloom, B. R. (1992) · The Lancet · doi:10.1016/0140-6736(92)91056-e · Cited by 103
Gruenheid, S., & Gros, P. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00049-1 · Cited by 101
The decaying genome ofMycobacterium leprae
Eiglmeier, K., Parkhill, J., Honoré, N., Garnier, T., Tekaia, F., Telenti, A., Klatser, P. R., James, K., THOMSON, N. R., Wheeler, P. R., et al. (2001) · Leprosy Review · doi:10.5935/0305-7518.20010047 · Cited by 100
Misra, N., Murtaza, A., Walker, B., Narayan, N., Misra, R. S., Ramesh, V., Singh, S., Colston, M. J., & Nath, I. (1995) · PubMed · Cited by 98
Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages
Sibley, L. D., Franzblau, S. G., & Krahenbuhl, J. L. (1987) · Infection and Immunity · doi:10.1128/iai.55.3.680-685.1987 · Cited by 95
Self-citationLahiri, R., Randhawa, B., & Krahenbuhl, J. L. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45700-0 · Cited by 95
Self-citationKoppel, E. A., Ludwig, I. S., Hernandez, M. S., Lowary, T. L., Gadikota, R. R., Tuzikov, A. B., Vandenbroucke‐Grauls, C. M. J. E., van Kooyk, Y., Appelmelk, B. J., & Geijtenbeek, T. B. H. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.03.003 · Cited by 94
Adams, L. B., Fukutomi, Y., & Krahenbuhl, J. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4173-4181.1993 · Cited by 93
Self-citationSchlesinger, L. S., & Horwitz, M. A. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.5.1031 · Cited by 89
The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.
Kaplan, G., Britton, W. J., Hancock, G. E., Theuvenet, W. J., Smith, K. A., Job, C. K., ROCHE, P. W., Molloy, A., Burkhardt, R., & Barker, J. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.4.993 · Cited by 85
Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes
McMurry, J. A., Sbai, H., Gennaro, M. L., Carter, E. J., Martin, W. D., & Groot, A. S. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2004.09.005 · Cited by 83
Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation
Holzer, T. J., Nelson, K. E., Crispen, R. G., & Andersen, B. R. (1986) · Infection and Immunity · doi:10.1128/iai.51.2.514-520.1986 · Cited by 82
Dinauer, M. C., Deck, M. B., & Unanue, E. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5581 · Cited by 81
Kai, M., Matsuoka, M., Nakata, N., Maeda, S., Gidoh, M., Maeda, Y., Hashimoto, K., Kobayashi, K., & Kashiwabara, Y. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13737.x · Cited by 81
Alcaïs, A., Sánchez, F. O. N., Thuc, N. V., Lap, V. D., Oberti, J., Lagrange, P. H., Schurr, E., & Abel, L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315174 · Cited by 81
Sampaio, E. P., Moraes, M. O., Nery, J. A. C., Santos, A. R., Matos, H. C., & Sarno, E. N. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00510.x · Cited by 77
The Development and Adaptation of the Semmes-Weinstein Monofilaments in Brazil
Lehman, L. F., Orsini, M. B. P., & Nicholl, A. R. J. (1993) · Journal of Hand Therapy · doi:10.1016/s0894-1130(12)80330-9 · Cited by 77
Arnoldi, J., Gerdes, J., & Flad, H.-D. (1990) · PubMed · Cited by 74
Hashimoto, K., Maeda, Y., Kimura, H. J., Suzuki, K., Masuda, A., Matsuoka, M., & Makino, M. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5167-5176.2002 · Cited by 72
Kang, T. J., Yeum, C. E., Kim, B. C., You, E., & Chae, G. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01926.x · Cited by 67
Williams, D. L., Spring, L., Gillis, T. P., Salfinger, M., & Persing, D. H. (1998) · Clinical Infectious Diseases · doi:10.1086/516313 · Cited by 66
Self-citationComparative mycobacterial genomics
Cole, S. T. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80090-8 · Cited by 63
HLA and Susceptibility to Leprosy
Serjeantson, S. W. (1983) · Immunological Reviews · doi:10.1111/j.1600-065x.1983.tb00711.x · Cited by 63
Thangaraj, H. S., Lamb, F. I., Davis, E. O., Jenner, P., Jeyakumar, L. H., & Colston, M. J. (1990) · Infection and Immunity · doi:10.1128/iai.58.6.1937-1942.1990 · Cited by 62
Effects of fixation on polymerase chain reaction detection of Mycobacterium leprae
Fiallo, P., Williams, D. L., Chan, G. P., et al. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.12.3095-3098.1992 · Cited by 61
Self-citationTruman, R. W., Fontes, A. N. B., de Miranda, A. B., Suffys, P. N., & Gillis, T. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2558-2565.2004 · Cited by 60
Self-citationInteraction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
Allegra, C. J., Boarman, D., Kovacs, J. A., et al. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114448 · Cited by 56
Santos, A. R., Balassiano, V., de Oliveira, M. L. W.-D.-R., Pereira, M. A. D. S., dos Santos, P. B., Degrave, W., & Suffys, P. N. (2001) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762001000800017 · Cited by 56
A family of dispersed repeats in Mycobacterium leprae
Woods, S. A., & Cole, S. T. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00552.x · Cited by 56
HLA class II immune response and suppression genes in leprosy.
Ottenhoff, T. H. M., & Rr, D. V. (1987) · PubMed · Cited by 55
Biological Implications of Mycobacterium leprae Gene Expression during Infection
Williams, D. L., Torrero, M. N., Wheeler, P. R., Truman, R. W., Yoder, M. A., Morrison, N., Bishai, W. R., & Gillis, T. P. (2004) · Microbial Physiology · doi:10.1159/000082081 · Cited by 55
Self-citationComparative genomics of the leprosy and tubercle bacilli
Brosch, R., Gordon, S. V., Eiglmeier, K., Garnier, T., & Cole, S. T. (2000) · Research in Microbiology · doi:10.1016/s0923-2508(00)00117-0 · Cited by 55
Shannon, E., MIRANDA, R. O., Morales, M. J., & Hastings, R. C. (1981) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1981.tb00169.x · Cited by 54
Continued proteomic analysis of Mycobacterium leprae subcellular fractions
Marques, M. A. M., Espinosa, B. J., da Silveira, E. K. X., Pessolani, M. C. V., Chapeaurouge, A., Perales, J., Dobos, K. M., Belisle, J. T., Spencer, J. S., & Brennan, P. J. (2004) · PROTEOMICS · doi:10.1002/pmic.200400945 · Cited by 51
Haanpää, M., Lockwood, D. N. J., & Hietaharju, A. (2004) · Leprosy Review · doi:10.47276/lr.75.1.7 · Cited by 50
Jacobs, W. R., Docherty, M., Curtiss, R., & Clark‐Curtiss, J. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1926 · Cited by 50
Binding of α2-laminins by pathogenic and non-pathogenic mycobacteria and adherence to Schwann cells
Marques, M. A. M., ANTÔNIO, V. L., Sarno, E. N., Brennan, P. J., & Pessolani, M. C. V. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-1-23 · Cited by 50
In Situ Type 1 Cytokine Gene Expression and Mechanisms Associated with Early Leprosy Progression
Stefani, M. M. A., Martelli, C. M. T., Gillis, T. P., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/378410 · Cited by 50
Self-citationDrug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system
Franzblau, S. G. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.12.2115 · Cited by 49
Moraes, M. O., Sarno, E. N., Teles, R. M. B., de Almeida, A. S., Saraiva, B. C. C., Nery, J. A. C., & Sampaio, E. P. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00158.x · Cited by 49
Transmission of Leprosy in Nude Mice
Chehl, S. K., Hastings, R. C., & Job, C. K. (1985) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1985.34.1161 · Cited by 46
Adams, L. B., Scollard, D. M., Ray, N. A., Cooper, A. M., Frank, A. A., Orme, I. M., & Krahenbuhl, J. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/338002 · Cited by 46
Self-citationNasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia
Beyene, D., Aseffa, A., Harboe, M., Kidane, D., Macdonald, M., Klatser, P. R., Bjune, G. A., & Smith, W. C. (2003) · Epidemiology and Infection · doi:10.1017/s0950268803001079 · Cited by 45
Shannon, E. J., & Sandoval, F. (1996) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979609007110 · Cited by 43
Peptidoglycan and Arabinogalactan of Mycobacterium Leprae
Draper, P., Kandler, O., & Darbre, A. (1987) · Microbiology · doi:10.1099/00221287-133-5-1187 · Cited by 42
Zodpey, S. P., Ambadekar, N. N., & Thakur, A. K. (2005) · Public Health · doi:10.1016/j.puhe.2004.04.007 · Cited by 41
Williams, D. L., Gillis, T. P., & Portaels, F. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00542.x · Cited by 40
Self-citationRole of Inducible Nitric Oxide Synthase in Resistance toMycobacterium lepraein Mice
Adams, L. B., Job, C. K., & Krahenbuhl, J. L. (2000) · Infection and Immunity · doi:10.1128/iai.68.9.5462-5465.2000 · Cited by 40
Self-citationSathish, M., Esser, R., Thole, J. E. R., & Clark‐Curtiss, J. E. (1990) · Infection and Immunity · doi:10.1128/iai.58.5.1327-1336.1990 · Cited by 39
Effects of Prednisolone Treatment on Cytokine Expression in Patients with Leprosy Type 1 Reactions
Andersson, A. K., Chaduvula, M., Atkinson, S. E., Khanolkar-Young, S., Jain, S., Suneetha, L. M., Suneetha, S. K., & Lockwood, D. N. J. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3725-3733.2005 · Cited by 39
Ji, B., Sow, S. O., Perani, E. G., Lienhardt, C., Diderot, V., & Grosset, J. H. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1115 · Cited by 39
Cambau, E., Sougakoff, W., & Jarlier, V. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb06674.x · Cited by 38
Genetics of susceptibility to infectious diseases: tuberculosis and leprosy as examples.
Marquet, S., & Schurr, E. (2001) · PubMed · Cited by 38
Antigenic Specificity of theMycobacterium lepraeHomologue of ESAT-6
Spencer, J. S., Marques, M. A. M., Lima, M. C. B. S., Junqueira‐Kipnis, A. P., Gregory, B. C., Truman, R. W., & Brennan, P. J. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.1010-1013.2002 · Cited by 38
Self-citationExpression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions
Aa, K., MUSONDA, A. C., Khanolkar-Young, S., Suneetha, S. K., & Lockwood, D. N. J. (2003) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02306.x · Cited by 37
Khanolkar-Young, S., Snowdon, D., & Lockwood, D. N. J. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00669.x · Cited by 37
Teased fibre studies in leprous neuropathy
Jacobs, J. M., Shetty, V. P., & Antia, N. H. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90237-1 · Cited by 33
Drlica, K., Xu, C., Wang, J. Y., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1594 · Cited by 33
Sela, S., & Clark‐Curtiss, J. E. (1991) · Gene · doi:10.1016/0378-1119(91)90114-q · Cited by 31
Hagge, D. A., Ray, N. A., Krahenbuhl, J. L., & Adams, L. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7771 · Cited by 30
Self-citationPrimary dapsone resistance in Cebu, The Philippines; cause for concern.
CRUZ, E. C. D. L., Cellona, R. V., Balagon, M. V., et al. (1996) · PubMed · Cited by 29
Assessment of cell mediated immunogenicity of Mycobacterium leprae-derived antigens
Maeda, Y., Gidoh, M., Ishii, N., Mukai, C., & Makino, M. (2003) · Cellular Immunology · doi:10.1016/s0008-8749(03)00078-9 · Cited by 29
Exploitation of gene knockout mice models to study the pathogenesis of leprosy
Krahenbuhl, J. L., & Adams, L. B. (2000) · Leprosy Review · doi:10.5935/0305-7518.20000090 · Cited by 29
Self-citationSave, M. P., Shetty, V. P., Shetty, K. T., & Antia, N. H. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00578.x · Cited by 27
Brennan, P. J., & Vissa, V. (2001) · Leprosy Review · doi:10.5935/0305-7518.20010050 · Cited by 27
Kulkarni, V. M., & Seydel, J. K. (2009) · Chemotherapy · doi:10.1159/000238174 · Cited by 25
The microbial physiologist's guide to the leprosy genome
Wheeler, P. R. (2001) · Leprosy Review · doi:10.5935/0305-7518.20010048 · Cited by 23
Anthony, L. S. D., Chatterjee, D., Brennan, P. J., & Nano, F. E. (1994) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1994.tb00456.x · Cited by 22
Hancock, G. E., Molloy, A., Kale, A. B. B., Kiessling, R. W., Becx-Bleumink, M., Cohn, Z. A., & Kaplan, G. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90027-9 · Cited by 21
Waters, M. F. (1983) · Tubercle · doi:10.1016/0041-3879(83)90018-1 · Cited by 20
Seydel, J. K., Richter, M., & Wempe, E. (1980) · PubMed · Cited by 19
The integrated genome map ofMycobacterium leprae
Eiglmeier, K., Simon, S., Garnier, T., & Cole, S. T. (2001) · Leprosy Review · doi:10.5935/0305-7518.20010054 · Cited by 18
Santos, D. O., Santos, S., Esquenazi, D., et al. (2001) · Japanese journal of leprosy · doi:10.5025/hansen.70.15 · Cited by 18
Increased levels of nitric oxide metabolites in urine from leprosy patients in reversal reaction
Schön, T., Gebre, N., Sundqvist, T., HABETMARIAM, H. S., Taye, E., & Britton, S. (1999) · Leprosy Review · doi:10.5935/0305-7518.19990011 · Cited by 16
Specific identification of Mycobacterium leprae by the polymerase chain reaction
Hackel, C., Houard, S. A., Portaels, F., Elsen, A. V., HERZOG, A., & Bollen, A. (1990) · Molecular and Cellular Probes · doi:10.1016/0890-8508(90)90054-4 · Cited by 16
Shepard, C. C., Rj, R., Levy, L., et al. (1986) · PubMed · Cited by 15
Polymerase chain reaction amplifying DNA coding for species-specific rRNA of Mycobacterium leprae.
Pattyn, S. R., Ursi, D., Ieven, M. M., et al. (1992) · PubMed · Cited by 14
Upregulation of T‐Cell‐Stimulating Activity of Mycobacteria‐Infected Macrophages
Kimura, H. J., Maeda, Y., Takeshita, F., Takaoka, L. E., Matsuoka, M., & Makino, M. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01472.x · Cited by 12
Schön, T., Leekassa, R., Gebre, N., Sundqvist, T., Bizuneh, E., & Britton, S. (2000) · Leprosy Review · doi:10.5935/0305-7518.20000040 · Cited by 10
CHOUDHURY, A., Mistry, N. F., & Antia, N. H. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb02457.x · Cited by 9
Leprosy in type I reaction and diabetes mellitus in a patient with HIV infection
Belliappa, A. D., Bhat, R., & Martis, J. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01582.x · Cited by 8
Cited by
Current and Past Strategies for Bacterial Culture in Clinical Microbiology
Lagier, J.-C., Edouard, S., Pagnier, I., Mediannikov, O., Drancourt, M., & Raoult, D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00110-14 · Cited by 655
Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 653
The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
Tobin, D. M., Vary, J. C., Ray, J. P., Walsh, G. S., Dunstan, S. J., Bang, N. D., Hagge, D. A., Khadge, S., King, M.-C., Hawn, T. R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.013 · Cited by 528
Leprosy now: epidemiology, progress, challenges, and research gaps
Rodrigues, L. C., & Lockwood, D. N. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70006-8 · Cited by 505
Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1
Lastória, J. C., & Abreu, M. A. M. M. D. (2014) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20142450 · Cited by 398
Metadata
- Authors
- Scollard, D. M., Adams, L. B., Gillis, T. P., Krahenbuhl, J. L., Truman, R. W., & Williams, D. L.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2006-04
- Volume
- 19
- Issue
- 2
- Pages
- 338-381
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2169420357
- Cited by
- 928
- References
- 190
- FWCI
- 19.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.